Centre for Obesity Research and Education, Monash University Medical School, Alfred Hospital, Melbourne, 3004, Australia.
JAMA. 2010 Feb 10;303(6):519-26. doi: 10.1001/jama.2010.81.
Adolescent obesity is a common and serious health problem affecting more than 5 million young people in the United States alone. Bariatric surgery is being evaluated as a possible treatment option. Laparoscopic adjustable gastric banding (gastric banding) has the potential to provide a safe and effective treatment.
To compare the outcomes of gastric banding with an optimal lifestyle program on adolescent obesity.
DESIGN, SETTING, AND PATIENTS: A prospective, randomized controlled trial of 50 adolescents between 14 and 18 years with a body mass index (BMI) higher than 35, recruited from the Melbourne, Australia, community, assigned either to a supervised lifestyle intervention or to undergo gastric banding, and followed up for 2 years. The study was performed between May 2005 and September 2008.
Weight loss. Secondary outcomes included change in metabolic syndrome, insulin resistance, quality of life, and adverse outcomes.
Twenty-four of 25 patients in the gastric banding group and 18 of 25 in lifestyle group completed the study. Twenty-one (84%) in the gastric banding and 3 (12%) in the lifestyle groups lost more than 50% of excess weight, corrected for age. Overall, the mean changes in the gastric banding group were a weight loss of 34.6 kg (95% CI, 30.2-39.0), representing an excess weight loss of 78.8% (95% CI, 66.6%-91.0%), 12.7 BMI units (95% CI, 11.3-14.2), and a BMI z score change from 2.39 (95% CI, 2.05-2.73) to 1.32 (95% CI, 0.98-1.66). The mean losses in the lifestyle group were 3.0 kg (95% CI, 2.1-8.1), representing excess weight loss of 13.2% (95% CI, 2.6%-21.0%), 1.3 BMI units (95% CI, 0.4-2.9), and a BMI z score change from 2.41 (95% CI, 2.21-2.66) to 2.26 (95% CI, 1.91-2.43). At entry, 9 participants (36%) in the gastric banding group and 10 (40%) in the lifestyle group had the metabolic syndrome. At 24 months, none of the gastric banding group had the metabolic syndrome (P = .008; McNemar chi(2)) compared with 4 of the 18 completers (22%) in the lifestyle group (P = .13). The gastric banding group experienced improved quality of life with no perioperative adverse events. However, 8 operations (33%) were required in 7 patients for revisional procedures either for proximal pouch dilatation or tubing injury during follow-up.
Among obese adolescent participants, use of gastric banding compared with lifestyle intervention resulted in a greater percentage achieving a loss of 50% of excess weight, corrected for age. There were associated benefits to health and quality of life.
ANZCTR Identifier: 12605000160639.
青少年肥胖是一个普遍且严重的健康问题,仅在美国就有超过 500 万名年轻人受到影响。减重手术正被评估为一种可能的治疗选择。腹腔镜可调节胃束带术(胃束带)有可能提供安全有效的治疗。
比较胃束带术与最佳生活方式方案对青少年肥胖的治疗效果。
设计、地点和患者:这是一项前瞻性、随机对照试验,纳入了 50 名年龄在 14 至 18 岁之间、BMI 高于 35 的澳大利亚墨尔本社区青少年,他们被分配到接受监督生活方式干预或接受胃束带术治疗,并随访 2 年。该研究于 2005 年 5 月至 2008 年 9 月进行。
体重减轻。次要结局包括代谢综合征、胰岛素抵抗、生活质量和不良结局的变化。
胃束带组 25 例患者中有 24 例和生活方式组 25 例患者中有 18 例完成了研究。胃束带组 21 例(84%)和生活方式组 3 例(12%)患者的体重减轻超过了 50%的多余体重,经年龄校正。总体而言,胃束带组的平均变化为体重减轻 34.6kg(95%CI,30.2-39.0),多余体重减轻 78.8%(95%CI,66.6%-91.0%),体重指数(BMI)降低 12.7 个单位(95%CI,11.3-14.2),BMI z 分数从 2.39(95%CI,2.05-2.73)变为 1.32(95%CI,0.98-1.66)。生活方式组的平均体重减轻量为 3.0kg(95%CI,2.1-8.1),多余体重减轻 13.2%(95%CI,2.6%-21.0%),BMI 降低 1.3 个单位(95%CI,0.4-2.9),BMI z 分数从 2.41(95%CI,2.21-2.66)变为 2.26(95%CI,1.91-2.43)。在入组时,胃束带组有 9 名(36%)参与者和生活方式组有 10 名(40%)参与者患有代谢综合征。24 个月时,胃束带组没有一人患有代谢综合征(P=0.008;McNemar χ2),而生活方式组 18 名完成者中有 4 人(22%)(P=0.13)。胃束带组的生活质量得到了改善,且无围手术期不良事件。然而,在随访期间,7 名患者中有 8 次(33%)需要进行修订手术,以治疗近端囊袋扩张或管道损伤。
在肥胖的青少年参与者中,与生活方式干预相比,使用胃束带术可使更多的患者达到多余体重减轻 50%的目标,且该数据经年龄校正。治疗效果与健康和生活质量的改善相关。
澳大利亚新西兰临床试验注册中心标识符:12605000160639。